X
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): AEF0117
Therapeutic Area: Psychiatry/Psychology Product Name: AEF0117
Highest Development Status: Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Indivior
Deal Size: $130.0 million Upfront Cash: $30.0 million
Deal Type: Collaboration June 08, 2021
Details:
Indivior has entered into a strategic collaboration with Aelis Farma ("Aelis"), a private biotechnology company based in Bordeaux, France, that includes an exclusive option and license agreement (the "Agreement") for the global rights to AEF0117.
Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace
